Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14)

Cancer Genetics and Cytogenetics

Volumn 173, Issue 1, 2007, Pages 51-56

  Guglielmelli, Tommasina ^a   Giugliano, Emilia ^a   Cappia, Susanna ^a   Papotti, Mauro ^a   Saglio, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; CCND1 GENE; CELL CYCLE REGULATION; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE NUMBER; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRISOMY; TRISOMY 11;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSLOCATION, GENETIC; TRISOMY;

EID: 33846794899     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.09.017     Document Type: Article

References (21)

1. Arnold A., Kim H.G., Gaz R.D., Eddy .R.L., Fukushima Y., Byers M.G., Shows T.B., and Kronemberg K.M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83 (1989) 2034-2040
2. Swedrdlow S.H., and Williams M.E. From centrocytic to mantle cell lymphoma. A clinicopathologic and molecular review of three decades. Hum Pathol 33 (2002) 7-20
3. Arnold A., and Papanikolaou A. Cyclin D1 in breast cancer pathogenesis. J Clin Oncol 23 (2005) 4215-4224
4. Donnellan R., and Cherry R. Cyclin D1 and human neoplasia. J Clin Pathol S1 (1998) 1-7
5. Pruneri G., Fabris S., Baldini L., Carboni N., Zagano S., Colombi M.A., Ciceri G., Lombardi L., Rocchi M., Buffa R., Maiolo A.T., and Neri A. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol 156 (2000) 1505-1513
6. Hoechtlen-Vollmar W., Menzel G., Bartl R., Lamerz R., Wick M., and Seidel D. Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance. Br J Haematol 109 (2000) 30-39
7. Rasmussen T., Knudsen L.M., and Johnsen H.E. Frequency and prognostic relevance of cyclin D1 dysregulation in multiple myeloma. Eur J Haematol 67 (2001) 296-330
8. Specht K., Haralambieva E., Bink K., Kremer M., Mandl-Weber S., Koch I., Tomer R., Hofler H., Schuuring E., Kluin P.M., Fend F., and Quintamilla-Martinez L. Different mechanisms of cyclin D1 gene overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 104 (2004) 1120-1126
9. Hideshima T., Bersagel W., Kuehl M., and Anderson K.C. Advances in biology of multiple myeloma: clinical applications. Blood 104 (2004) 607-618
10. Agnelli L., Bicciato S., Mattioli M., Fabris S., Intini D., Verdelli D., Baldini L., Morabito F., Callea V., Lombardi L., and Neri A. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocation. J Clin Oncol 23 (2005) 1-43
11. Bergsagel P.L., and Michael K. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23 (2005) 6333-6338
12. Bergsagel P.L., Michael K.W., Zhan F., Sawyer J., Barlogie B., and Shaughnessy J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106 (2005) 296-303
13. Tabernero D., San Miguel J.F., Garcia Sanz M., Najera L., Garcia-Isidoro M., Perez-Simon J.A., Gonzales M., Wiegant J., Raap A.K., and Orfao A. Incidence of chromosomal numerical changes in multiple myeloma; fluorescence in situ hybridization analysis using 15 chromosome-specific probes. Am J Pathol 49 (1996) 153-161
14. Perez Simon J.A., Garcia-Sanz R., Tabernero M.D., Almeida J., Gonzales M., Fernandez-Calvo J., Moro M.J., Hernandez J.M., San Miguel J.F., and Orfao A. Prognostic value of numerical chromosome aberration in multiple myeloma: a FISH analysis of 15 different chromosomes. Blood 91 (1998) 3366-3371
15. Soverini S., Cavo M., Cellini C., Terragna C., Zamagni E., Ruggeri D., Testoni N., Tosi P., De Vivo A., Amabile M., Grafone T., Ottaviani E., Giannini B., Cangini D., Bonifazi F., Neri A., Fabris S., Tura S., Baccarani M., and Martinelli G. Cyclin D1 overexpression is a favourable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. Blood 102 (2003) 1588-1594
16. Lam E.W., Glassford J., Banerji L., Thomas N.S., Sicinski P., and Kllauss G.G. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem 275 (2000) 3479-3484
17. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin A.S. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19 (1999) 5785-5799
18. Schuring E. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes. A review. Gene 159 (1995) 83-86
19. Gabrea A., Bersagel P.L., Chesi M., Shou Y., and Kuehl W.M. Insertion of excised IgH switch sequences cause overexpression of cyclin D1 in a myeloma tumour cell. Mol Cell 3 (1999) 119-123
20. Fonseca R., Barlogie B., Bataille R., Bastard C., Bergsagel P.L., Chesi M., Davies F.E., Drach J., Greipp P.R., Kirsch I.R., Kuehl W.M., Hemandez J.M., Minvielle S., Pilarski L.M., Shaghnessy Jr. J.D., Stewart A.K., and Avet-Loiseau H. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64 (2004) 1546-1558
21. Fonseca R., Debes-Marun C.S., Picken E.B., Dewald G.W., Bryany S.C., Winkler J.M., Blood E., Oken M.M., Santana-Davila R., Gonzales-Paz N., Kyle R.A., Gertz M.A., Dispensieri A., Lacy M.Q., and Greipp P.R. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Blood 102 (2003) 2562-2567